Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia

Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia

This study compared the clinical outcomes and safety of meropenem–colistin versus meropenem–tigecycline in the treatment of adult patients with carbapenem-resistant <i>Acinetobacter baumannii</i> (CRAB) pneumonia. A retrospective observational study of patients with CRAB pneumonia was pe...

Full description

Bibliographic Details
Main Authors: Jae-Min Park, Kyung-Sook Yang, You-Seung Chung, Ki-Byung Lee, Jeong-Yeon Kim, Sun-Bean Kim, Jang-Wook Sohn, Young-Kyung Yoon
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Antibiotics
Subjects:
<i>Acinetobacter baumannii</i>
meropenem
tigecycline
colistin
Online Access:https://www.mdpi.com/2079-6382/10/8/903

Similar Items

Similar Items